Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
Causse X, Cadranel JF, Potier P, Hanslik B, Denis J, Renou C, Delasalle P; Club de Réflexion des Cabinets et Groupes d’Hépato-Gastroentérologie (CREGG); Association Nationale des hépato-Gastroentérologues des Hôpitaux généraux de France (ANGH). Causse X, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2015 May;27(5):544-9. doi: 10.1097/MEG.0000000000000306. Eur J Gastroenterol Hepatol. 2015. PMID: 25822863
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohort.
Halfon P, Ouzan D, Asselah T, Renou C, Allègre T, Delasalle P, Lafeuillade A, Cadranel JF, Haddad N, Khiri H, Pénaranda G, Bourlière M; Iliade Investigators. Halfon P, et al. Among authors: renou c. Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):720-6. doi: 10.1016/j.clinre.2014.06.004. Epub 2014 Jul 14. Clin Res Hepatol Gastroenterol. 2014. PMID: 25034356
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.
Garioud A, Heng R, Amiot X, Rémy AJ, Ollivier-Hourmand I, Mokhtari C, Medmoun M, Renou C, Zougmoré H, Pulwermacher P, Lucidarme D, Rosa-Hézode I, Causse X, Arotcarena R, Zanditenas D, Halfon P, Pariente A, Cadranel JF; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux (ANGH), France. Garioud A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1270-1274. doi: 10.1097/MEG.0000000000001450. Eur J Gastroenterol Hepatol. 2019. PMID: 31219848 Clinical Trial.
Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium.
Pariente A, Chazouilleres O, Causse X, Hanslik B, Arpurt JP, Henrion J, Rosa I, Renou C, Garioud A, Corpechot C; DESCRIPT and DESCRIPT Study Groups. Pariente A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e197-e205. doi: 10.1097/MEG.0000000000002011. Eur J Gastroenterol Hepatol. 2021. PMID: 33252413
Hepatitis E virus in HIV-infected patients.
Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allègre T, Poggi C, Pénaranda G, Cordier F, Nicand E; ANGH. Renou C, et al. AIDS. 2010 Jun 19;24(10):1493-9. doi: 10.1097/QAD.0b013e32833a29ab. AIDS. 2010. PMID: 20467291
Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations.
Pariente A, Lahmek P, Duprat C, Denis J, Faroux R, Renou C, Nalet B, Morin T, Cadranel JF; Investigator Group belonging to Association Nationale des Gastroentérologues des Hôpitaux Généraux (ANGH). Pariente A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1297-302. doi: 10.1097/meg.0b013e32833bb4b0. Eur J Gastroenterol Hepatol. 2010. PMID: 20964260
106 results